Literature DB >> 23949063

Benefits of inpatient multidisciplinary rehabilitation in multiple sclerosis.

Sabine Salhofer-Polanyi1, Judith Windt, Harald Sumper, Hermine Grill, Maria Essmeister, Gudrun Diermayr, Karin Zebenholzer, Fritz Leutmezer, Gudrun Zulehner, Karl Vass, Susanne Asenbaum-Nan.   

Abstract

BACKGROUND: Rehabilitation is often recommended to MS-patients but data on its efficacy is limited.
OBJECTIVE: To evaluate the benefit of inpatient multidisciplinary rehabilitation.
METHODS: A rater-blinded, randomized, waiting list controlled exploratory study. 19 participants completed the study with ten allocated to the intervention and nine to the waiting list group. Assessment of outcome-parameters was done at baseline and after 3 months. Time Walking Tests (TWTs) and 9 Hole Peg Test were used to objectively assess the level of activity, Functional-Assessment-in-MS and MS-Self Efficacy-Scale to assess participation and quality of life and Expanded Disability Status Scale (EDSS) to assess bodily function. Additionally Rivermead Mobility Index, Berg Balance Scale, Tinetti-Test, MS-Functional Composite and a rater-blinded evaluation of a video-analysis on walking performance was done.
RESULTS: Mean change scores of Timed 50 meter Walk (p = 0.014), walking speed (p = 0.034), 2- (p = 0.204) and 6-Minute Walk (p = 0.027) indicated an improvement favoring inpatient multidisciplinary rehabilitation. We could not demonstrate a benefit for upper limb function and some improvement was seen in other outcome-parameters without reaching statistical significance. EDSS remained unchanged.
CONCLUSION: Inpatient multidisciplinary rehabilitation is effective in MS patients with positive impact on the level of activity as measured by TWTs covering both short and long distance ambulation.

Entities:  

Keywords:  2-Minute walk; 6-Minute walk; Multiple sclerosis; inpatient; level of activity; rehabilitation

Mesh:

Year:  2013        PMID: 23949063     DOI: 10.3233/NRE-130956

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  6 in total

1.  Uphill and Downhill Walking in Multiple Sclerosis: A Randomized Controlled Trial.

Authors:  Afshin Samaei; Amir Hoshang Bakhtiary; Abdolhamid Hajihasani; Elham Fatemi; Fatemeh Motaharinezhad
Journal:  Int J MS Care       Date:  2016 Jan-Feb

2.  The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.

Authors:  Helen Tedeholm; Bengt Skoog; Vera Lisovskaja; Björn Runmarker; Olle Nerman; Oluf Andersen
Journal:  J Neurol       Date:  2015-02-26       Impact factor: 4.849

3.  Predictors of hospital-based multidisciplinary rehabilitation effects in persons with multiple sclerosis: a large-scale, single-centre study.

Authors:  Elisabetta Groppo; Alessio Signori; Maria Pia Sormani; Cristina Grosso; Loredana La Mantia; Davide Cattaneo; Marco Rovaris
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-04-16

Review 4.  Physical exercise improves quality of life, depressive symptoms, and cognition across chronic brain disorders: a transdiagnostic systematic review and meta-analysis of randomized controlled trials.

Authors:  Marieke J H Begemann; Margot I E Slot; Meenakshi Dauwan; Edwin H M Lee; Philip Scheltens; Iris E C Sommer
Journal:  J Neurol       Date:  2019-08-14       Impact factor: 4.849

5.  Personalised inpatient multidisciplinary rehabilitation elicits clinically relevant improvements in physical function in patients with multiple sclerosis - The Danish MS Hospitals Rehabilitation Study.

Authors:  Lars G Hvid; Tobias Gaemelke; Ulrik Dalgas; Mette K Slipsager; Peter V Rasmussen; Thor Petersen; Michael Nørgaard; Anders G Skjerbaek; Finn Boesen
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-02-17

6.  Longer term effectiveness of inpatient multidisciplinary rehabilitation on health-related quality of life in MS patients: a pragmatic randomized controlled trial - The Danish MS Hospitals Rehabilitation Study.

Authors:  Finn Boesen; Michael Nørgaard; Philipp Trénel; Peter Vestergaard Rasmussen; Thor Petersen; Brita Løvendahl; Jan Sørensen
Journal:  Mult Scler       Date:  2017-10-06       Impact factor: 6.312

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.